Skip to main content

Neurogenic Bowel Dysfunction

Neurogenic bowel dysfunction (NBD) is impaired colonic and anorectal function from a lesion or disease of the nervous system, producing constipation, fecal incontinence, or both in the same patient.[1][2] It is common in spinal cord injury (SCI), multiple sclerosis (MS), and spina bifida, the three populations referenced throughout this page, and overlaps mechanistically with the urinary neurogenic lower urinary tract dysfunction these patients often also carry.[2][3][4] For the general classification of overlapping constipation, fecal incontinence, and defecatory dysfunction, see Defecatory Disorders; this page focuses on the neurologic populations and their bowel-program escalation.

Phenotype by Lesion Level​

Neurogenic bowel is broadly described as reflexic (upper motor neuron) or areflexic (lower motor neuron), mirroring the UMN/LMN framework used for neurogenic bladder:

PatternTypical lesionAnorectal physiologyClinical consequence
Reflexic (UMN)SCI or disease above the conus, intact sacral reflex arcPreserved reflex rectal contraction and anal sphincter tone; voluntary control lostRetained stool with difficult, non-voluntary evacuation; digital stimulation and reflex-triggered emptying are often effective
Areflexic (LMN)Conus, cauda equina, or sacral-root injury (including many spina bifida patients)Loss of the anorectal reflex arc and often of sphincter toneSlow colonic transit with a flaccid, incontinent outlet; manual evacuation is often needed

Injury level is a guide, not a substitute for examining reflexes, perineal sensation, and anal tone in the individual patient; the urinary and bowel phenotypes do not always track together even in the same patient.[5][6]

Prevalence and Impact​

Reported rates vary widely by population, definition, and whether constipation, incontinence, or both are counted. In a U.S. National Spina Bifida Patient Registry cohort of 3,670 patients age 5 or older with myelomeningocele and neurogenic bowel, only 45% were fully fecally continent (fewer than one accident per month); antegrade enemas were the most commonly used treatment and were associated with the highest rate of continence, an observational association confounded by underlying severity rather than a controlled comparison.[4] Bowel dysfunction in MS is described as highly prevalent, with constipation and fecal incontinence that can coexist and alternate over time, driven by a mix of altered neurologic pathways, polypharmacy, mobility, and toileting access rather than a single mechanism.[3]

Bowel dysfunction affects quality of life independently of urinary status, drives caregiver burden, and increases health-care utilization and cost across these populations.[1][3]

Evaluation​

Evaluation tracks stool form, frequency, evacuation time, leakage, abdominal symptoms, skin breakdown from stool contact, and whether bowel care provokes autonomic symptoms. In patients at risk of autonomic dysreflexia (SCI at or above T6), bowel care — distension, catheterization, and manual stimulation of the rectum — is a recognized trigger; see Autonomic Dysreflexia for current recognition and management rather than repeating emergency treatment here.[5] A bowel diary (stool form, timing, leakage, diet, and medication) is the practical first step and the basis for titrating the program below.

Bowel-Program Escalation​

Bowel programs are individualized to stool pattern, mobility, hand function, caregiver availability, and patient goals rather than applied as a fixed ladder; a 2010 systematic review of the SCI bowel-management evidence found that non-pharmacologic interventions (including scheduled and reflex-triggered evacuation) are supported mainly by lower-quality evidence, while pharmacologic bowel regimens have stronger supporting evidence, and concluded that most patients need more than one intervention to achieve an effective routine.[6] A broadly similar menu is described across SCI, MS, and spina bifida, escalating roughly as follows:

  1. Diet, fluid, and scheduled toileting. Fiber and fluid titration, a consistent time of day tied to the gastrocolic reflex, and positioning for abdominal-wall assistance.
  2. Oral and rectal pharmacologic measures. Stimulant or osmotic laxatives, suppositories, and digital rectal stimulation in reflexic patients.
  3. Transanal irrigation (TAI). Scheduled rectal/colonic emptying with water, using a cone, catheter, or balloon-catheter system, to produce planned evacuation and reduce interval leakage. In a 87-patient multicenter randomized trial in SCI, TAI improved the Cleveland Clinic constipation score (10.3 vs 13.2, p = 0.0016), the St. Mark's fecal incontinence score (5.0 vs 7.3, p = 0.015), and the Neurogenic Bowel Dysfunction score (10.4 vs 13.3, p = 0.048) compared with best-supportive conservative bowel management over a 10-week period.[7] A 2025 systematic review supports TAI for constipation and/or fecal incontinence, with most supporting evidence from neurogenic and post-colorectal-resection populations.[8] A manufacturer-sponsored multinational expert consensus review gives practical patient-selection, training, and troubleshooting guidance for TAI and should be read as expert and industry-supported guidance rather than an independent professional-society recommendation.[9]
  4. Antegrade continence enema (ACE / Malone antegrade continence enema, MACE). A catheterizable channel, most often an appendiceal conduit (appendicostomy) or a cecostomy tube, used for antegrade large-volume colonic irrigation when retrograde (transanal) measures fail or are not feasible; it is frequently constructed together with a urinary catheterizable channel and bladder augmentation in the same operation in spina bifida patients.[4] A systematic review and meta-analysis of 17 observational studies (426 adults, 165 with fecal incontinence, 209 with constipation, 52 with both; median follow-up 39 months) reported a pooled success rate (continued use at follow-up) of 74.3% (95% CI 66.1-82.6%) overall, 83.6% (75.0-92.1%) for fecal incontinence, and 67.7% (55.1-80.3%) for constipation.[10]
  5. Colostomy or other diverting stoma. Reserved for failure of the above measures or patient preference for a simpler, time-saving routine.

Surgical Measures: Colostomy and Quality of Life​

A diverting colostomy is sometimes viewed by patients and clinicians as a last resort, but the available comparative data do not support that framing uniformly:

  • In a controlled comparison of 26 SCI patients with a colostomy and 26 matched SCI patients without one (matched for injury level, completeness, time since injury, age, and sex), a validated SCI quality-of-life questionnaire showed no significant difference in general well-being, emotional, social, or work functioning between groups, supporting earlier consideration of colostomy in patients with major bowel dysfunction rather than reserving it only after every other option fails.[11]
  • In a retrospective interview-based cohort of SCI patients who underwent stoma formation (mean 17 years after injury, after a mean of 8 years of poor bowel function), mean weekly time spent on bowel care fell from 10.3 hours before stoma formation to 1.9 hours afterward (p < 0.0001); 18 patients reported greater independence and 25 described quality of life as much better, while complications occurred in 14 patients (eight with leakage of mucus, blood, or pus per rectum, three with parastomal hernia, and three with bowel obstruction).[12]

Both are small, retrospective or cross-sectional comparisons without randomization, and neither establishes that colostomy should replace a trial of transanal irrigation or ACE; they do support discussing colostomy as a legitimate option earlier in the bowel-program ladder when conservative and antegrade measures have not controlled symptoms.

See Also​

References​

1. Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury: clinical evaluation and rehabilitative management. Arch Phys Med Rehabil. 1997;78(3 Suppl):S86-S102.

2. Awad RA. Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease. World J Gastroenterol. 2011;17(46):5035-5048. doi:10.3748/wjg.v17.i46.5035

3. Preziosi G, Gordon-Dixon A, Emmanuel A. Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. Degener Neurol Neuromuscul Dis. 2018;8:79-90. doi:10.2147/DNND.S138835

4. Kelly MS, Wiener JS, Liu T, et al. Neurogenic bowel treatments and continence outcomes in children and adults with myelomeningocele. J Pediatr Rehabil Med. 2020;13(4):685-693. doi:10.3233/PRM-190667

5. Coggrave M, Ash D, Adcock C, et al. Guidelines for management of neurogenic bowel dysfunction in individuals with central neurological conditions. Multidisciplinary Association of Spinal Cord Injured Professionals (MASCIP); 2012. mascip.co.uk

6. Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010;48(10):718-733. doi:10.1038/sc.2010.14

7. Christensen P, Bazzocchi G, Coggrave M, et al. A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006;131(3):738-747. doi:10.1053/j.gastro.2006.06.004

8. Vollebregt PF, Baeten CIM, Drewes AM, et al. Transanal irrigation: bridging the gap in treatment for chronic constipation and/or faecal incontinence-a systematic review and management guidance. Colorectal Dis. 2025;27(11):e70274. doi:10.1111/codi.70274

9. Emmanuel AV, Krogh K, Bazzocchi G, et al. Consensus review of best practice of transanal irrigation in adults. Spinal Cord. 2013;51(10):732-738. doi:10.1038/sc.2013.86

10. Chan DS, Delicata RJ. Meta-analysis of antegrade continence enema in adults with faecal incontinence and constipation. Br J Surg. 2016;103(4):322-327. doi:10.1002/bjs.10051

11. Randell N, Lynch AC, Anthony A, Dobbs BR, Roake JA, Frizelle FA. Does a colostomy alter quality of life in patients with spinal cord injury? A controlled study. Spinal Cord. 2001;39(5):279-282. doi:10.1038/sj.sc.3101156

12. Branagan G, Tromans A, Finnis D. Effect of stoma formation on bowel care and quality of life in patients with spinal cord injury. Spinal Cord. 2003;41(12):680-683. doi:10.1038/sj.sc.3101529